[Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
Brenard
R
R
Hôp St-Joseph, Gilly.
Closon
M L
ML
Fevery
J
J
Hautekeete
M
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000628:therapy* / Q000821:virology*; D003131:Combined Modality Therapy; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000628:therapy* / Q000821:virology*; D018579:Patient Selection; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons